OBJECTIVE

To investigate the contribution of alterations in brain structure and function to cognitive function and their interactions in individuals with diabetes and patients with type 2 diabetes mellitus (T2DM).

RESEARCH DESIGN AND METHODS

This population-based study included 2,483 participants who underwent structural MRI (n = 569 with normal glucose metabolism [NGM], n = 1,353 with prediabetes, and n = 561 with T2DM) and cognitive testing. Of these, 2145 participants also underwent functional MRI (n = 496 NGM, n = 1,170 prediabetes, and n = 479 T2DM). Multivariate linear regression models were used to assess the association of brain volume and functional connectivity with cognition, as well as the association of brain volume and functional connectivity.

RESULTS

Compared with NGM participants, those with T2DM had lower brain volume in a wide range of brain regions and stronger functional connectivity between the bilateral thalamus and brain functional network (visual network and default mode network), and those with prediabetes had lower brain volume in specific local regions (subcortical gray matter volume and subcortical subregions [bilateral thalamus, bilateral nucleus accumbens, and right putamen]) and stronger functional connectivity between the right thalamus and visual network. Cognition was associated with greater right thalamus volume and lower functional connectivity between the right thalamus and visual network. Functional connectivity between the right thalamus and visual network was associated with lower right thalamus volume.

CONCLUSIONS

Cognition was associated with greater brain volume and lower functional connectivity in T2DM. Increased functional connectivity may indicate a compensatory mechanism for reduced brain volume that begins in the prediabetic phase.

Type 2 diabetes mellitus (T2DM) triggers a well-described cascade of neurological disorders, including stroke, dementia, and depression, which may result in some degree of cognitive impairment (1,2). The pathogenesis of T2DM-related cognitive dysfunction is multifactorial and remains incompletely understood (3). Hyperglycemia may induce vascular endothelium dysfunction, which then increases the risk of cerebrovascular diseases (4), thus leading to brain structural abnormalities, including lacunar infarcts, white matter abnormalities, and brain atrophy (5). Atrophy in the brain regions has been reported to affect large-scale cortical communication, cognition, and perceptual function (68). This suggests that brain structural abnormalities may be key drivers of cognitive disturbance (9). T2DM studies have revealed not only structural volume abnormalities but also functional connectivity abnormalities (1012). Increased connectivity between cortical and subcortical areas has been reported in T2DM (13). A meta-analysis revealed both structural and functional abnormalities in the cognitive control regions of the brain in some patients with psychiatric and neurological disorders (14). Despite these findings, the relationship between abnormalities of brain structure and function and cognitive dysfunction remains contentious. Changes in functional connectivity may promote cognition dysfunction but could also represent compensation for structural damage by the protective mechanism of the brain. Therefore, assessment of brain structural volume is insufficient to understand the underlying brain mechanisms of T2DM-related cognition completely. The existing literature lacks accurate assessments of diabetes status and joint analysis of multimodal MRI; the interaction between structural and functional changes in the brain has yet to be elucidated. Furthermore, existing studies of brain abnormalities in T2DM and prediabetes are usually limited by small sample size, leading to inconsistent findings (2). Studies with large sample sizes are needed to confirm and expand previous findings (15) and provide new insights into T2DM-induced cognitive impairment. These mechanisms in prediabetes, if explored, may provide a window of opportunity for delaying or preventing brain disease in individuals with T2DM (16).

In this study, we provide the first comprehensive analysis of brain abnormalities in a large population-based cohort of patients with T2DM and prediabetes using multimodal MRI. We aimed to study structural and functional brain alterations and their interactions and the cognitive consequences in T2DM and prediabetes. We hypothesized that the relationship between brain structural volume and functional connectivity in individuals with diabetes might indicate compensatory mechanisms that exist even in prediabetic brains.

Study Population

The PRECISE (Polyvascular Evaluation for Cognitive Impairment and Vascular Events) study is an ongoing population-based prospective cohort study, with longitudinal collection of cardiovascular and cerebrovascular events and cognitive assessments. Participants in the PRECISE study included community-dwelling adults age 50–75 years based on cluster sampling from six villages and four communities of Lishui city in southeastern China (17). In the current study, data from the baseline assessment (May 2017 to September 2019) were used. In the baseline assessment, 3,067 participants were included, with 2,487 undergoing brain MRI scans. Four structural MRI (sMRI) scans were excluded from the study because of data processing errors, resulting in 2,483 sMRI scans included in the final analysis (flowchart in Supplementary Fig. 1). Of these, 2,145 functional MRI (fMRI) scans were included in the final analysis (flowchart in Supplementary Fig. 2). The PRECISE study was approved by the institutional review boards (IRBs) at all participating institutions, the ethics committee at Beijing Tiantan Hospital (IRB approval no. KY2017-010-01; Beijing, China), and the ethics committee at Lishui Hospital (IRB approval no. 2016-42; Lishui, China). All participants provided written informed consents before entering the study.

Prediabetes and T2DM Status

For all participants, fasting plasma glucose (FPG) and HbA1c were measured from fasting blood samples. Participants with a history of diabetes or treatment with hypoglycemic agents or insulin did not undergo the oral glucose tolerance test. Participants without a history of diabetes underwent a standardized oral glucose tolerance test (2 h, 75 g). For these individuals, fasting blood glucose level, HbA1c level, and medication information were used to determine prediabetes and T2DM status (flowchart in Supplementary Fig. 3). All tests were completed and centralized in Lishui City Central Hospital. Fasting glucose and postload glucose were measured by the enzymatic hexokinase method on two automatic analyzers (Abbott Architect C16000 and Abbott Architect I2000). HbA1c was measured by the ion-exchange chromatography method on an automatic analyzer (Tosoh INDIA HLC-723GB).

Prediabetes and T2DM status were defined according to the American Diabetes Association 2019 diagnostic criteria (18). Participants were considered to have prediabetes if they had an FPG ≥5.6 to 6.9 mmol/L or 2-h postload glucose ≥7.8 to 11.0 mmol/L or HbA1c ≥5.7 to 6.4% (39–47 mmol/mol). Diagnosis of T2DM was made by confirmation of self-reported diabetes that was previously diagnosed by a physician, current use of antidiabetic agents, FPG ≥7.0 mmol/L, 2-h postload glucose ≥11.1 mmol/L, or HbA1c ≥6.5% (48 mmol/mol). The remaining participants were considered to have normal glucose metabolism (NGM).

MRI Acquisition

Brain MRI data were acquired using a 3.0 Tesla MRI scanner (Ingenia 3.0T; Philips, Best, the Netherlands). Structural MRI data were acquired with high-resolution T1-weighted three-dimensional fast field echo structural scans (repetition time 6.7 ms; echo time 3.0 ms; voxel size 1 × 1 × 1 mm). Resting-state fMRI data were acquired with a gradient echo-planar imaging sequence. To reach steady state, six dummy scans were used before recording the data (repetition time 2,100 ms; echo time 30 ms; n = 38 slices; gap 0 mm; voxel size 3 × 3 × 4 mm; n = 180 volume measures).

Data Preprocessing

Preprocessing of sMRI data was performed by applying the FreeSurfer image analysis suite (https://surfer.nmr.mgh.harvard.edu) to T1-weighted MRI scans, which generated brain volumetric measures. In this report, we used the Desikan-Killiany atlas (19) for sMRI parcellation. FreeSurfer results were visually checked for segmentation and registration accuracy. The brain volumetric measures used in the current study included total brain gray matter volume, total white matter volume, gray matter and white matter volume in the left and right hemispheres, and deep subcortical gray matter volume (defined as total volume of the amygdala, hippocampus, caudate, pallidum, nucleus accumbens, putamen, and thalamus). We performed further functional connectivity analysis of regions with structural abnormalities demonstrated in prediabetes.

Preprocessing of fMRI data was performed using Statistical Parametric Mapping software (www.fil.ion.ucl.ac.uk/spm) and the Data Processing Assistant for Resting-State fMRI toolbox (20). The middle slice was used as the reference frame for slice timing. The fMRI time series was realigned using a six-parameter rigid-body spatial transformation to compensate for head movement effects. Functional and structural images were coregistered and warped to the Montreal Neurological Institute space. This was followed by resampling to 3-mm isotropic voxels, smoothening with a 6-mm full width at half-maximum Gaussian kernel, detrending, and band-pass filtering (0.01–0.08 Hz). The global mean signal, six head-motion parameters, mean signal in cerebrospinal fluid, and mean signal in white matter were regressed out as nuisance covariates to account for the effects of motion and nonneuronal blood oxygenation level–dependent fluctuations. The brain was parcellated into 246 regions (123 in each hemisphere) using the Human Brainnetome atlas (Supplementary Table 1), which provides information on functional connections based on the Desikan-Killiany atlas (21). We constructed brain network functional connectivity by calculating the Pearson correlation coefficient between each pair of brain regions and then converted to z scores using the Fisher r-to-z transformation. The whole-brain functional connectivity matrix for each participant was generated. The sparsity of the network was set at 0.15, which maintained the high connectedness of the brain networks and simultaneously removed as many spurious correlations as possible. The cerebral cortex was then mapped to seven functional networks according to the Yeo atlas (22), which included visual, somatomotor, dorsal attention, ventral attention, limbic, frontoparietal, and default mode networks (Fig. 1A).

Figure 1

Schematic representation of functional connectivity between the cerebral cortex and subcortical subregions. A: Seven cortical functional networks were provided by the Yeo atlas (22). Subcortical subregions are indicated by white arrows, including the amygdala, hippocampus, caudate, pallidum, nucleus accumbens, putamen, and thalamus. Connection lines indicate connections between all subcortical subregions and the cerebral cortex. B: Compared with NGM participants, those with prediabetes had significantly stronger functional connectivity between the cortex and right thalamus, and those with T2DM had significantly stronger functional connectivity between the cortex and subcortical subregions, including the bilateral thalamus and left caudate. These subcortical subregions are indicated by black arrows; connection lines indicate connections between these subcortical subregions and the cerebral cortex. C: Compared with NGM participants, those with prediabetes and T2DM had significantly stronger functional connectivity between the bilateral thalamus and cortical functional networks. There was a significant increase in functional connectivity between the right thalamus and visual network in prediabetes. There was a significant increase in functional connectivity between the bilateral thalamus and visual network and functional connectivity between the bilateral thalamus and default mode network in T2DM. The bilateral thalamus is shown by black arrows; connection lines indicate connections between the thalamus and cortical functional networks. Details of the 246 regions in Human Brainnetome atlas (21) are provided in Supplementary Table 1. L, left; R, right.

Figure 1

Schematic representation of functional connectivity between the cerebral cortex and subcortical subregions. A: Seven cortical functional networks were provided by the Yeo atlas (22). Subcortical subregions are indicated by white arrows, including the amygdala, hippocampus, caudate, pallidum, nucleus accumbens, putamen, and thalamus. Connection lines indicate connections between all subcortical subregions and the cerebral cortex. B: Compared with NGM participants, those with prediabetes had significantly stronger functional connectivity between the cortex and right thalamus, and those with T2DM had significantly stronger functional connectivity between the cortex and subcortical subregions, including the bilateral thalamus and left caudate. These subcortical subregions are indicated by black arrows; connection lines indicate connections between these subcortical subregions and the cerebral cortex. C: Compared with NGM participants, those with prediabetes and T2DM had significantly stronger functional connectivity between the bilateral thalamus and cortical functional networks. There was a significant increase in functional connectivity between the right thalamus and visual network in prediabetes. There was a significant increase in functional connectivity between the bilateral thalamus and visual network and functional connectivity between the bilateral thalamus and default mode network in T2DM. The bilateral thalamus is shown by black arrows; connection lines indicate connections between the thalamus and cortical functional networks. Details of the 246 regions in Human Brainnetome atlas (21) are provided in Supplementary Table 1. L, left; R, right.

Close modal

Statistical Analysis

The clinical characteristics of the participants are presented as mean ± SD, median with interquartile range (continuous variables), and percentage (categorical variables). Comparisons between glycemic metabolic groups (prediabetes, T2DM, and NGM) were based on ANOVA (continuous variables with normal distribution), the Kruskal-Wallis test (continuous variables with skewed distribution) and the Pearson χ2 test (categorical variables). A P value <0.05 was considered statistically significant.

Group differences were analyzed using two procedures of multivariate ANCOVA (MANCOVA) (with age, sex, and education level as covariates). The first MANCOVA determined if the three groups (prediabetes, T2DM, and NGM) differed with respect to brain structural volume. The second MANCOVA was computed to determine if the three groups differed with regard to brain functional connectivity between cortex and subcortical subregions. The MANCOVAs were followed by separate ANCOVAs for each dependent variable (with age, sex, and education level as covariates). Post hoc two-sample t tests, in a pairwise manner, within the areas identified by the ANCOVA, were used to identify differential abnormal brain regions among the three groups. Multiple comparison corrections were performed using the Bonferroni correction. All reported P values were based on two-sided tests, and P < 0.05 was considered statistically significant.

Multiple linear regression analysis was used to investigate the association of Montreal Cognitive Assessment (MoCA) score with brain volume and brain functional connectivity. Multiple linear regression analysis was used to investigate the association between brain volume and functional connectivity. Correlations were calculated for all participants. All data were standardized with the z score normalization method before regression. Analyses were adjusted for potential confounders, notably age (years), sex (male or female), and education level (illiteracy, elementary school, middle or high school, or college or above) (model 1) and additionally adjusted for BMI (continuous), hypertension (self-reported hypertension previously diagnosed by a physician, current use of antihypertensive agents, systolic blood pressure ≥140 mmHg, or diastolic blood pressure ≥90 mmHg), ratio of total to HDL cholesterol, history of stroke (yes or no), and history of heart disease (yes or no) (model 2). Finally, multiple linear regression analysis was used to evaluate the effect of brain structural volume and brain functional connectivity on cognition. Confounding variables (age, sex, education level, BMI, hypertension, ratio of total to HDL cholesterol, history of stroke, and history of heart disease) were regressed out in the model. All statistical analyses were performed using SAS 9.4 (SAS Institute, Inc., Cary, NC). P < 0.05 was considered statistically significant.

Data and Resource Availability

All data sets generated or analyzed in the current study are available from the corresponding authors on reasonable request.

Study Sample Characteristics

The present report included cross-sectional data from 3,067 participants who completed the baseline assessment between May 2017 and September 2019. The sMRI data set included 569 (22.9%) participants with NGM, 1,353 (54.5%) with prediabetes, and 561 (22.6%) with T2DM (total N = 2,483). A cognitive assessment test was performed in 2,457 participants. The mean age of these participants was 61.4 years, and 53.4% were women. The sample characteristics are summarized in Table 1. Participants with prediabetes and T2DM were significantly older, had a lower education level, and had more cardiovascular risks compared with NGM participants.

Table 1

Clinical characteristics of participants

NGMPrediabetesT2DMP
Demographics     
 Age, years 59.8 ± 6.1 61.4 ± 6.5 63.2 ± 6.9 <0.001 
 Female sex, % 52.5 53.5 54.4 0.813 
Glucose metabolism     
 Fasting glucose, mmol/L 5.1 ± 0.3 5.6 ± 0.5 7.8 ± 2.4 <0.001 
 2-h postload glucose, mmol/L 6.0 ± 1.1 7.3 ± 1.7 12.8 ± 3.7 <0.001 
 HbA1c, % 5.4 ± 0.2 5.8 ± 0.3 7.1 ± 1.4 <0.001 
 HbA1c, mmol/mol 35.4 ± 2.6 39.5 ± 3.4 54.5 ± 15.1 <0.001 
Cardiovascular risk factors     
 BMI, kg/m2 23.2 ± 2.7 24.0 ± 3.0 24.7 ± 3.2 <0.001 
 Systolic BP, mmHg 124.7 ± 15.6 130.2 ± 15.6 135.3 ± 16.8 <0.001 
 Diastolic BP, mmHg 73.6 ± 8.6 75.8 ± 9.0 76.8 ± 8.9 <0.001 
 Hypertension, % 29.8 43.3 61.7 <0.001 
 Ratio of total to HDL cholesterol 3.8 ± 1.1 4.1 ± 1.2 4.2 ± 1.1 <0.001 
 Triglycerides, mmol/L 1.5 ± 1.1 1.8 ± 1.2 2.1 ± 1.5 <0.001 
 eGFR, mL/min/1.73 m2 103.0 ± 11.1 101.2 ± 13.0 101.6 ± 13.3 0.039 
 History of stroke, % 2.1 2.4 4.3 0.033 
 History of heart disease, % 5.8 8.4 12.1 <0.001 
Medication use, %     
 Lipid lowering 1.9 4.0 8.4 <0.001 
 Antihypertensive 17.1 25.6 40.3 <0.001 
MoCA 22.1 ± 4.6 21.5 ± 5.0 21.4 ± 4. 7 0.020 
Lifestyle factors, %     
 Smoking status    0.005 
  Never 63.7 68.5 68.1  
  Current 23.8 19.9 16.2  
  Former 12.5 11.6 15.7  
 Education level    0.030 
  Illiteracy or elementary school 35.9 41.2 45.5  
  Middle or high school 55.6 51.3 47.4  
  College or above 8.5 7.5 7.1  
NGMPrediabetesT2DMP
Demographics     
 Age, years 59.8 ± 6.1 61.4 ± 6.5 63.2 ± 6.9 <0.001 
 Female sex, % 52.5 53.5 54.4 0.813 
Glucose metabolism     
 Fasting glucose, mmol/L 5.1 ± 0.3 5.6 ± 0.5 7.8 ± 2.4 <0.001 
 2-h postload glucose, mmol/L 6.0 ± 1.1 7.3 ± 1.7 12.8 ± 3.7 <0.001 
 HbA1c, % 5.4 ± 0.2 5.8 ± 0.3 7.1 ± 1.4 <0.001 
 HbA1c, mmol/mol 35.4 ± 2.6 39.5 ± 3.4 54.5 ± 15.1 <0.001 
Cardiovascular risk factors     
 BMI, kg/m2 23.2 ± 2.7 24.0 ± 3.0 24.7 ± 3.2 <0.001 
 Systolic BP, mmHg 124.7 ± 15.6 130.2 ± 15.6 135.3 ± 16.8 <0.001 
 Diastolic BP, mmHg 73.6 ± 8.6 75.8 ± 9.0 76.8 ± 8.9 <0.001 
 Hypertension, % 29.8 43.3 61.7 <0.001 
 Ratio of total to HDL cholesterol 3.8 ± 1.1 4.1 ± 1.2 4.2 ± 1.1 <0.001 
 Triglycerides, mmol/L 1.5 ± 1.1 1.8 ± 1.2 2.1 ± 1.5 <0.001 
 eGFR, mL/min/1.73 m2 103.0 ± 11.1 101.2 ± 13.0 101.6 ± 13.3 0.039 
 History of stroke, % 2.1 2.4 4.3 0.033 
 History of heart disease, % 5.8 8.4 12.1 <0.001 
Medication use, %     
 Lipid lowering 1.9 4.0 8.4 <0.001 
 Antihypertensive 17.1 25.6 40.3 <0.001 
MoCA 22.1 ± 4.6 21.5 ± 5.0 21.4 ± 4. 7 0.020 
Lifestyle factors, %     
 Smoking status    0.005 
  Never 63.7 68.5 68.1  
  Current 23.8 19.9 16.2  
  Former 12.5 11.6 15.7  
 Education level    0.030 
  Illiteracy or elementary school 35.9 41.2 45.5  
  Middle or high school 55.6 51.3 47.4  
  College or above 8.5 7.5 7.1  

Data are presented as mean ± SD or percentage. A total of 2,483 participants underwent sMRI, of whom 2,145 also underwent fMRI.

Fasting glucose values were available in n = 2,481. The 2-h postload glucose values were available in n = 2,209. HbA1c values were available in n = 2,481. Ratio of total to HDL cholesterol values were available in n = 2,481. Triglycerides values were available in n = 2,481. Estimated glomerular filtration rate values were available in n = 2,481. MoCA values were available in n = 2,457. BP, blood pressure.

Brain Structural Abnormalities in Prediabetes and T2DM

Statistically significant results of MANCOVA were seen for brain structural volume (Wilks Λ = 0.964; P < 0.001). Total gray matter, total white matter, left and right cortical gray matter, left and right cerebral white matter, and subcortical gray matter regions showed significant differences among the three groups (all P < 0.05). Additional pairwise comparisons among the three groups are shown in Table 2.

Table 2

T2DM, prediabetes, and NGM brain volume measures

Brain volume, cm3NGM (n = 569)Prediabetes (n = 1,353)T2DM (n = 561)FP
Total gray matter 585.88 ± 39.9 581.88 ± 41.64 568.3 ± 38.46* 14.256 <0.001 
Total white matter 457.78 ± 43.42 453.56 ± 47 0.02 442.32 ± 42.02* 6.027 0.002 
Subcortical gray matter 45.36 ± 3.37 44.88 ± 3.52 43.80 ± 3.33* 10.269 <0.001 
Left cerebral cortex gray matter 215.51 ± 16.22 213.93 ± 17.13 208.95 ± 15.8* 11.67 <0.001 
Right cerebral cortex gray matter 215.61 ± 16.24 214.26 ± 16.98 209.54 ± 15.79* 10.008 <0.001 
Left cerebral white matter 229.49 ± 21.9 227.32 ± 23.71 221.71 ± 21.21* 5.898 0.003 
Right cerebral white matter 228.29 ± 21.64 226.25 ± 23.51 220.61 ± 20.96* 6.07 0.002 
Thalamus left 7.11 ± 0.71 7.01 ± 0.73 6.76 ± 0.65* 11.961 <0.001 
Thalamus right 6.69 ± 0.59 6.6 ± 0.65 6.41 ± 0.59* 9.745 <0.001 
Caudate left 3.11 ± 0.38 3.07 ± 0.43 3.04 ± 0.39* 2.285 0.102 
Caudate right 3.18 ± 0.4 3.15 ± 0.43 3.13 ± 0.41 1.606 0.201 
Putamen left 4.49 ± 0.49 4.45 ± 0.5 4.31 ± 0.5* 10.56 <0.001 
Putamen right 4.55 ± 0.49 4.48 ± 0.5 4.35 ± 0.5* 10.801 <0.001 
Pallidum left 1.99 ± 0.23 1.98 ± 0.24 1.99 ± 0.29 0.497 0.608 
Pallidum right 1.97 ± 0.23 1.95 ± 0.24 1.95 ± 0.27 0.106 0.899 
Hippocampus left 3.98 ± 0.33 3.96 ± 0.38 3.86 ± 0.34* 5.932 0.003 
Hippocampus right 4.15 ± 0.36 4.13 ± 0.41 4.04 ± 0.37* 3.836 0.022 
Amygdala left 1.55 ± 0.17 1.54 ± 0.19 1.5 ± 0.18* 3.616 0.027 
Amygdala right 1.74 ± 0.18 1.72 ± 0.21 1.69 ± 0.19* 2.442 0.087 
Nucleus accumbens left 0.37 ± 0.09 0.36 ± 0.09 0.34 ± 0.08* 13.116 <0.001 
Nucleus accumbens right 0.48 ± 0.07 0.46 ± 0.08 0.44 ± 0.07* 14.503 <0.001 
Brain volume, cm3NGM (n = 569)Prediabetes (n = 1,353)T2DM (n = 561)FP
Total gray matter 585.88 ± 39.9 581.88 ± 41.64 568.3 ± 38.46* 14.256 <0.001 
Total white matter 457.78 ± 43.42 453.56 ± 47 0.02 442.32 ± 42.02* 6.027 0.002 
Subcortical gray matter 45.36 ± 3.37 44.88 ± 3.52 43.80 ± 3.33* 10.269 <0.001 
Left cerebral cortex gray matter 215.51 ± 16.22 213.93 ± 17.13 208.95 ± 15.8* 11.67 <0.001 
Right cerebral cortex gray matter 215.61 ± 16.24 214.26 ± 16.98 209.54 ± 15.79* 10.008 <0.001 
Left cerebral white matter 229.49 ± 21.9 227.32 ± 23.71 221.71 ± 21.21* 5.898 0.003 
Right cerebral white matter 228.29 ± 21.64 226.25 ± 23.51 220.61 ± 20.96* 6.07 0.002 
Thalamus left 7.11 ± 0.71 7.01 ± 0.73 6.76 ± 0.65* 11.961 <0.001 
Thalamus right 6.69 ± 0.59 6.6 ± 0.65 6.41 ± 0.59* 9.745 <0.001 
Caudate left 3.11 ± 0.38 3.07 ± 0.43 3.04 ± 0.39* 2.285 0.102 
Caudate right 3.18 ± 0.4 3.15 ± 0.43 3.13 ± 0.41 1.606 0.201 
Putamen left 4.49 ± 0.49 4.45 ± 0.5 4.31 ± 0.5* 10.56 <0.001 
Putamen right 4.55 ± 0.49 4.48 ± 0.5 4.35 ± 0.5* 10.801 <0.001 
Pallidum left 1.99 ± 0.23 1.98 ± 0.24 1.99 ± 0.29 0.497 0.608 
Pallidum right 1.97 ± 0.23 1.95 ± 0.24 1.95 ± 0.27 0.106 0.899 
Hippocampus left 3.98 ± 0.33 3.96 ± 0.38 3.86 ± 0.34* 5.932 0.003 
Hippocampus right 4.15 ± 0.36 4.13 ± 0.41 4.04 ± 0.37* 3.836 0.022 
Amygdala left 1.55 ± 0.17 1.54 ± 0.19 1.5 ± 0.18* 3.616 0.027 
Amygdala right 1.74 ± 0.18 1.72 ± 0.21 1.69 ± 0.19* 2.442 0.087 
Nucleus accumbens left 0.37 ± 0.09 0.36 ± 0.09 0.34 ± 0.08* 13.116 <0.001 
Nucleus accumbens right 0.48 ± 0.07 0.46 ± 0.08 0.44 ± 0.07* 14.503 <0.001 

Data are presented as mean ± SD.

*

Diabetes vs. NGM (P < 0.05).

Diabetes vs. prediabetes (P < 0.05; Bonferroni corrected).

Prediabetes vs. NGM (P < 0.05).

Compared with those with NGM, individuals with prediabetes had significantly lower volume of subcortical gray matter (P = 0.015) and subcortical subregions, including the bilateral thalamus (left P = 0.009; right P = 0.009), bilateral nucleus accumbens (left P = 0.021; right P = 0.003), and right putamen (P = 0.024). Individuals with T2DM had significantly lower volume of total gray and white matter, left and right cortical gray matter, left and right cerebral white matter, subcortical gray matter regions, and all subcortical subregions except the bilateral pallidum and right caudate (all P < 0.05).

Compared with participants with prediabetes, those with T2DM had significantly lower volume of total gray and white matter, left and right cortical gray matter, left and right cerebral white matter, subcortical gray matter regions, and all subcortical subregions except the bilateral pallidum and bilateral caudate (all P < 0.05). All abovementioned comparisons among groups survived Bonferroni correction for multiple comparisons.

Brain Functional Abnormalities in Prediabetes and T2DM

Because the volume of subcortical structures was lower in prediabetes and T2DM, further analysis was focused on subcortical regions. We next investigated the functional connectivity of these structurally abnormal regions. Statistically significant results of MANCOVA were seen for brain functional connectivity between cortex and subcortical subregions (Wilks Λ = 0.980; P = 0.035). Functional connectivity between cortex and subcortical subregions, including the bilateral thalamus (left P = 0.024; right P = 0.001) and left caudate (P = 0.001), differed significantly among the three groups by ANCOVA. Results of the pairwise comparisons are presented in Fig. 1B. On the basis of the results of structural and functional analyses, we found that the thalamus showed reduced volume and increased functional connectivity in prediabetes. We further examined group differences in functional connectivity between the thalamus and cerebral cortex functional networks. Statistically significantly different functional connectivity between the visual network and bilateral thalamus (left P = 0.011; right P < 0.001) and between the default mode network and bilateral thalamus (left P = 0.026; right P = 0.007) among the three groups was shown by ANCOVA. Additional pairwise comparisons among the three groups showed that compared with NGM participants, those with prediabetes had significantly stronger functional connectivity between the visual network and right thalamus (P = 0.003). Individuals with T2DM had significantly stronger functional connectivity between the visual network and bilateral thalamus (left P = 0.006; right P < 0.001) and between the default mode network and bilateral thalamus (left P = 0.024; right P = 0.006) compared with those with NGM (Fig. 1C). There were no significant differences in functional connectivity of the thalamus and cortical functional networks between prediabetes and T2DM groups. All abovementioned comparisons among groups survived Bonferroni correction for multiple comparisons.

Associations of Cognition With Brain Volume

After full adjustment, no significant relationship was found between MoCA score and cortical gray matter volume (β = 0.03; 95% CI −0.003 to 0.062; P = 0.078). MoCA score was associated greater subcortical gray matter volume (β = 0.098; 95% CI 0.058–0.138; P < 0.001) and greater brain volume in the bilateral thalamus (left β = 0.108; 95% CI 0.070–0.147; P < 0.001; right β = 0.082; 95% CI 0.043–0.121; P < 0.001) (Supplementary Table 3).

Associations of Cognition With Brain Functional Connectivity

After full adjustment, MoCA score was associated with lower functional connectivity between the left thalamus and functional networks, including the somatomotor network (β = −0.048; 95% CI −0.083 to −0.013; P = 0.007) and ventral attention network (β = −0.040; 95% CI −0.076 to −0.005; P = 0.025), and higher functional connectivity between the left thalamus and limbic network (β = 0.040; 95% CI 0.005–0.075; P = 0.026). MoCA score was associated with lower functional connectivity between the right thalamus and visual network (β = −0.041; 95% CI −0.077 to −0.004; P = 0.029) (Supplementary Table 4).

Associations of Brain Volume With Brain Functional Connectivity

After full adjustment, left thalamic volume was associated with lower functional connectivity between the left thalamus and visual network (β = −0.075; 95% CI −0.124 to −0.026; P = 0.003). Right thalamic volume was associated with lower functional connectivity between the right thalamus and visual network (β = −0.064; 95% CI −0.113 to −0.015; P = 0.010) (Supplementary Table 5).

Influence of Brain Structural Volume and Brain Functional Connectivity on Cognition

After full adjustment, MoCA score was associated with greater right thalamus volume (β = 0.066; 95% CI 0.026–0.107; P = 0.001) and lower functional connectivity between the right thalamus and visual network (β = −0.033; 95% CI −0.069 to 0.002; P = 0.068).

In a large population-based study, we showed that individuals with T2DM had lower brain volume in widespread brain regions and stronger functional connectivity in specific brain regions, in comparison with those with NGM. Notably, these diabetes-related brain abnormalities were present even before clinical diagnosis of T2DM in individuals with prediabetes. Furthermore, cognitive function was associated with greater brain volume but lower functional connectivity; higher functional connectivity was associated with lower brain volume.

We found that participants with T2DM had lower total brain volume and regional brain volume, including total gray matter, total white matter and subcortical gray matter, and subcortical subregions. These results are consistent with those of previous studies (10). The pathological mechanisms by which T2DM may cause a reduction in brain volume include hyperglycemia, impaired insulin sensitivity, insulin resistance, amyloid β accumulation, τ hyperphosphorylation, inflammation, and oxidative stress (16,23); these characteristics resemble those of Alzheimer disease. Brain damage may result from reduced cerebral glucose metabolism or brain atrophy, deteriorating neurodegenerative diseases, or accelerating cognitive decline (24,25). We have expanded on existing studies of brain subcortical and subcortical subregions in T2DM. In our study, significant reduction was seen in the volume of all subcortical regions in those with T2DM, except in the bilateral pallidum and bilateral caudate regions. The results in those with prediabetes were more specific in region, such as the bilateral thalamus, bilateral nucleus accumbens, and right putamen. Perhaps atrophy of the subcortical area is associated with insulin dysregulation. Several studies have demonstrated that insulin receptors, which are widely distributed in the brain, can modulate neurogenesis, brain function, and energy balance (26). Expression of insulin receptors is highest in the cortex and some subcortical regions, including the thalamus, hippocampus, caudate, putamen, and amygdala, which play important roles in cognition (27). Furthermore, we found that cognition was associated with an increase in the volume of subcortical subregions, including the thalamus, putamen, pallidum, hippocampus, amygdala, and nucleus accumbens, independent of cortical volume. These results further suggest that the reduced volume of the subcortical subregions is associated with cognitive dysfunction. Reductions in the volume of the thalamus were already present in those with prediabetes, suggesting that brain mechanisms are already altered before the onset of diabetes. Disrupted connections between the cortical and subcortical regions may also cause cognitive impairment, depending on their participation in various brain regions (28). Our further analysis of subcortical subregions revealed that functional connectivity between the thalamus and cerebral cortex, including visual and default mode functional networks, was significantly enhanced in those with T2DM. Functional connectivity between the thalamus and visual network was significantly enhanced in those with prediabetes. Higher MoCA score was related to lower functional connectivity between the thalamus and visual network. This negative correlation may be caused by the volume effect. Accompanied by volume decline, reduced cognitive function and increased functional connectivity were found, suggesting that increased functional connectivity may be a compensatory mechanism in reduced volume associated with cognitive dysfunction. The current study showed that both structural volume and functional connectivity in the thalamus were altered in participants with prediabetes when compared with the control group and were closely linked to cognitive performance. Thalamic abnormalities are commonly found in neurological and psychiatric illnesses. However, structural and functional abnormalities may have different effects on cognitive function. Previous studies have shown that atrophy in the thalamus and other subcortical subregions contributes to cognitive impairment (29). We found that the volume of the thalamus was associated with lower functional connectivity between the thalamus and visual network. Although the estimated effect size for these correlations was small, the significant trends exhibited and the relative magnitude of effect size deserve further attention. These findings have important implications for potential mechanisms of diabetes impairment of cognition. Structural damage in the brain may be compensated for by functional reorganization (30); increased functional connectivity may be a significant compensatory mechanism for cognitive dysfunction related to brain atrophy and neurodegeneration in individuals with T2DM and prediabetes. Compared with participants with prediabetes, those with T2DM had significantly lower cortical and subcortical subregion volume, except for bilateral pallidum and bilateral caudate regions. Brain functional connectivity did not differ between prediabetes and T2DM groups, suggesting that this compensatory pattern may begin in prediabetes and persist in diabetes, but the difference in compensation between prediabetes and diabetes may not be significant. The compensatory mechanism of the thalamus and visual network connection was present in prediabetes, suggesting the existence of potentially abnormal features of visual information transmission before the onset of T2DM. Furthermore, the dynamic balance between the default mode network and other brain regions seems to be important for maintaining normal cognitive function. We suggest that increased functional connectivity between the thalamus and default network may be a compensatory mechanism in relation to reduced volume of the thalamus. This mechanism was not detected in prediabetic brains. This may be a sign of compensation or maladaptation (31), indicating that the degree of brain injury in prediabetes may be insufficient to trigger this compensatory mechanism in the default mode network (32).

Collectively, the current study provides new insights into cognitive mechanisms occurring in the brains of patients with T2DM and suggests the existence of enhanced functional connectivity through cortical and subcortical regions as a compensatory pattern for cognitive impairment related to structural brain damage. Strikingly, this compensatory pattern is already evident in prediabetic brains. Some cerebral small vessel diseases and neurodegenerative diseases, such as stroke, dementia, Alzheimer disease, and other diseases, often coexist in T2DM and may occur via a range of underlying mechanisms (33). We found the absolute value of β for structural volume was greater than the absolute value of β for functional connectivity in the multiple linear regression model, suggesting that brain structural volume has a greater effect on cognition than brain functional connectivity. This finding could provide new insights into the brain mechanisms of T2DM-related cognitive dysfunction, suggesting that structural brain volume merits closer attention in the prevention of T2DM-related cognitive changes.

The strengths of this study include a large population-based investigation that is reasonably representative of the general population. The prevalence of prediabetes (54.3%) and T2DM (22.7%) in the PRECISE study was similar to the prevalence reported in nationwide population-based surveys (prediabetes 57.7% and T2DM 22.5% in 2010 [34] and prediabetes 45.8% and T2DM 20.2% in 2013 [35] in the age range of 60–69 years) (36). We used multimodal MRI to perform a comprehensive analysis of brain functional and structural abnormalities in those with T2DM and prediabetes. The findings were robust and extended our current knowledge of the mechanisms underlying T2DM. However, we acknowledge that this study has some limitations. First, we did not collect detailed microvascular information or conduct detailed assessment for mild cognitive impairment or dementia; only MoCA was performed for baseline cognitive assessment. We will add full-dimensional microvascular information collection and cognitive assessment to the phase 2 follow-up data collection and analyze in detail. Second, because of the cross-sectional design of this study, we cannot infer any conclusions about how the development of diabetes affects brain abnormalities. We will continue to explore potential mechanisms of the cognitive impact of diabetes development in future longitudinal studies in PRECISE. Third, although we adjusted for many potential confounders, we cannot exclude residual confounding or the effect of unmeasured confounders, such as physical activity, diet, and alcohol; this should be done in future studies. Finally, this study is reliant on a Chinese community cohort and, therefore, should be combined with other population studies to generalize our conclusions.

In conclusion, we investigated brain structural and functional abnormalities in T2DM and prediabetes using a large population-based cohort. We demonstrated that smaller brain volume and stronger functional connectivity were present in the T2DM and prediabetic cortical and subcortical regions. Level of cognitive function is associated with greater brain volume and lower functional connectivity. These findings support the concept that increased brain functional connectivity may be a compensatory mechanism for cognitive dysfunction associated with reduced brain volume, beginning in prediabetes. The present research reported neuroimaging biomarkers for cognitive dysfunction in prediabetes. These findings will advance understanding of the cognitive mechanisms in individuals with T2DM and prediabetes and help to establish prevention strategies for neurological disorders in the prediabetes stage.

Clinical trial reg. no. NCT03178448, clinicaltrials.gov

This article contains supplementary material online at https://doi.org/10.2337/figshare.21912837.

J.Jin., C.L., and W.Z. contributed equally to this work.

Acknowledgments. The authors thank the staff and participants of the PRECISE study for their important contributions.

Funding. This research received support from National Key R&D Program of China (grants 2016YFC0901002 and 2022YFC2504900), Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (grant 2019-I2M-5-029), Key Science & Technologies R&D Program of Lishui City (grant 2019ZDYF18), Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents, and Beijing Natural Science Foundation (grant Z200016).

Duality of Interest. This research received support from AstraZeneca Investment (China) Co., Ltd. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. J.Jin., Y.P., T.L., and Yo.W. verified the quality and accuracy of research and clinical data. J.Jin. and T.L. conceptualized and designed the study. C.L. and W.Z. contributed to data analysis and manuscript writing. C.L., Y.P., and Y.J. contributed to statistical analysis. C.L. and Y.Z. contributed to quality control of the data. C.L., W.Z., Z.Z., J.C., H.N., and W.W. contributed to discussion and interpretation of the data. Y.P., J.Jia., X.C., Z.Z., Z.L., X.M., Yi.W., H.L., H.Z., S.W., and T.W. contributed to the data acquisition. Y.P., J.Jia., X.C., P.S.S., and T.L. contributed to critical revision of the report. T.L. and Yo.W. approved the final manuscript version. T.L. and Yo.W. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Geijselaers
SLC
,
Sep
SJS
,
Stehouwer
CDA
,
Biessels
GJ
.
Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review
.
Lancet Diabetes Endocrinol
2015
;
3
:
75
89
2.
van Sloten
TT
,
Sedaghat
S
,
Carnethon
MR
,
Launer
LJ
,
Stehouwer
CDA
.
Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression
.
Lancet Diabetes Endocrinol
2020
;
8
:
325
336
3.
Biessels
GJ
,
Despa
F
.
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
.
Nat Rev Endocrinol
2018
;
14
:
591
604
4.
Palacio
S
,
McClure
LA
,
Benavente
OR
,
Bazan
C
3rd
,
Pergola
P
,
Hart
RG
.
Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study
.
Stroke
2014
;
45
:
2689
2694
5.
Moran
C
,
Phan
TG
,
Chen
J
, et al
.
Brain atrophy in type 2 diabetes: regional distribution and influence on cognition
.
Diabetes Care
2013
;
36
:
4036
4042
6.
Ding
L
,
Gold
JI
.
The basal ganglia’s contributions to perceptual decision making
.
Neuron
2013
;
79
:
640
649
7.
Saalmann
YB
,
Kastner
S
.
Cognitive and perceptual functions of the visual thalamus
.
Neuron
2011
;
71
:
209
223
8.
Chen
J
,
Zhang
J
,
Liu
X
, et al
.
Abnormal subcortical nuclei shapes in patients with type 2 diabetes mellitus
.
Eur Radiol
2017
;
27
:
4247
4256
9.
Moran
C
,
Beare
R
,
Wang
W
,
Callisaya
M
;
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
.
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
.
Neurology
2019
;
92
:
e823
e830
10.
Vergoossen
LW
,
Schram
MT
,
de Jong
JJ
, et al
.
White matter connectivity abnormalities in prediabetes and type 2 diabetes: the Maastricht study
.
Diabetes Care
2020
;
43
:
201
208
11.
Liu
H
,
Liu
J
,
Peng
L
, et al
.
Changes in default mode network connectivity in different glucose metabolism status and diabetes duration
.
Neuroimage Clin
2019
;
21
:
101629
12.
Zhang
Z
,
Zhang
B
,
Wang
X
, et al
.
Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: insights from clinical and functional neuroimaging studies
.
Diabetes Care
2019
;
42
:
1274
1283
13.
Zhang
H
,
Hao
Y
,
Manor
B
, et al
.
Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes
.
Diabetes
2015
;
64
:
1025
1034
14.
Lukito
S
,
Norman
L
,
Carlisi
C
, et al
.
Comparative meta-analyses of brain structural and functional abnormalities during cognitive control in attention-deficit/hyperactivity disorder and autism spectrum disorder
.
Psychol Med
2020
;
50
:
894
919
15.
Marek
S
,
Tervo-Clemmens
B
,
Calabro
FJ
, et al
.
Reproducible brain-wide association studies require thousands of individuals
.
Nature
2022
;
603
:
654
660
16.
Schneider
ALC
,
Selvin
E
,
Sharrett
AR
, et al
.
Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
.
Diabetes Care
2017
;
40
:
1514
1521
17.
Pan
Y
,
Jing
J
,
Cai
X
, et al
.
Prevalence and vascular distribution of multiterritorial atherosclerosis among community-dwelling adults in southeast China
.
JAMA Netw Open
2022
;
5
:
e2218307
18.
American Diabetes Association
.
2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019
.
Diabetes Care
2019
;
42
(
Suppl. 1
):
S13
S28
19.
Desikan
RS
,
Ségonne
F
,
Fischl
B
, et al
.
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
.
Neuroimage
2006
;
31
:
968
980
20.
Chao-Gan
Y
,
Yu-Feng
Z
.
DPARSF: a MATLAB toolbox for “pipeline” data analysis of resting-state fMRI
.
Front Syst Neurosci
2010
;
4
:
13
21.
Fan
L
,
Li
H
,
Zhuo
J
, et al
.
The Human Brainnetome atlas: a new brain atlas based on connectional architecture
.
Cereb Cortex
2016
;
26
:
3508
3526
22.
Yeo
BT
,
Krienen
FM
,
Sepulcre
J
, et al
.
The organization of the human cerebral cortex estimated by intrinsic functional connectivity
.
J Neurophysiol
2011
;
106
:
1125
1165
23.
Mo
D
,
Liu
S
,
Ma
H
, et al
.
Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
.
Drug Des Devel Ther
2019
;
13
:
2769
2776
24.
Biessels
GJ
,
Strachan
MW
,
Visseren
FL
,
Kappelle
LJ
,
Whitmer
RA
.
Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
.
Lancet Diabetes Endocrinol
2014
;
2
:
246
255
25.
Li
W
,
Risacher
SL
,
Huang
E
;
Alzheimer’s Disease Neuroimaging Initiative
.
Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort
.
Neurology
2016
;
87
:
595
600
26.
Kleinridders
A
,
Ferris
HA
,
Cai
W
,
Kahn
CR
.
Insulin action in brain regulates systemic metabolism and brain function
.
Diabetes
2014
;
63
:
2232
2243
27.
Kullmann
S
,
Kleinridders
A
,
Small
DM
, et al
.
Central nervous pathways of insulin action in the control of metabolism and food intake
.
Lancet Diabetes Endocrinol
2020
;
8
:
524
534
28.
O’Brien
JT
,
Erkinjuntti
T
,
Reisberg
B
, et al
.
Vascular cognitive impairment
.
Lancet Neurol
2003
;
2
:
89
98
29.
Yi
H-A
,
Möller
C
,
Dieleman
N
, et al
.
Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer’s disease
.
J Neurol Neurosurg Psychiatry
2016
;
87
:
425
432
30.
Schoonheim
MM
,
Geurts
JJ
,
Barkhof
F
.
The limits of functional reorganization in multiple sclerosis
.
Neurology
2010
;
74
:
1246
1247
31.
Schoonheim
MM
,
Hulst
HE
,
Brandt
RB
, et al
.
Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis
.
Neurology
2015
;
84
:
776
783
32.
Sumowski
JF
,
Rocca
MA
,
Leavitt
VM
, et al
.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS
.
Neurology
2014
;
82
:
1776
1783
33.
Bharadwaj
P
,
Wijesekara
N
,
Liyanapathirana
M
, et al
.
The link between type 2 diabetes and neurodegeneration: roles for amyloid-β, amylin, and tau proteins
.
J Alzheimers Dis
2017
;
59
:
421
432
34.
Xu
Y
,
Wang
L
,
He
J
, et al.;
2010 China Noncommunicable Disease Surveillance Group
.
Prevalence and control of diabetes in Chinese adults
.
JAMA
2013
;
310
:
948
959
35.
Wang
L
,
Gao
P
,
Zhang
M
, et al
.
Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013
.
JAMA
2017
;
317
:
2515
2523
36.
Pan
Y
,
Jing
J
,
Cai
X
, et al
.
PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)—a population-based prospective cohort study: rationale, design and baseline participant characteristics
.
Stroke Vasc Neurol
2021
;
6
:
145
151
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.